Vivoryon Therapeutics Eulerpool vesti

Vivoryon Therapeutics Eulerpool News

Vivoryon Therapeutics Akcija Vesti

Vivoryon Therapeutics праћен је од стране многих новинара и инвеститора широм света. Најсвежије Vivoryon Therapeutics вести окупљамо овде.

• 12. септембар ·

  Yahoo
  Vivoryon Therapeutics N.V. Reports H1 2024 Progress Marked by Compelling Kidney Function Data and Execution of Strategy to Advance Varoglutamstat in Kidney Disease
• 5. септембар ·

  Yahoo
  Vivoryon Therapeutics N.V. Announces Completion of Share Capital Reduction and Change to Articles of Association
• 5. септембар ·

  Yahoo
  Vivoryon Therapeutics N.V. to Report Half Year 2024 Financial Results on September 12, and to Host KOL Event on September 30, 2024
• 13. август ·

  Yahoo
  Here's Why We're Watching Vivoryon Therapeutics' (AMS:VVY) Cash Burn Situation
• 18. јул ·

  Yahoo
  Vivoryon Therapeutics N.V. Announces New Data Showing Unique Treatment Effects of Varoglutamstat on Kidney Function in Patients with Diabetes and Outlines Proposed Clinical Development Plan in Diabetic Kidney Disease
• 9. јул ·

  Yahoo
  Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on Progress in Kidney Disease
• 21. јун ·

  Yahoo
  Vivoryon Therapeutics N.V. Reports Outcome of 2024 Annual General Meeting
• 23. мај ·

  Yahoo
  Vivoryon Therapeutics N.V. Reports Q1 2024 Financial Results and New Data Reinforcing Strategic Focus in Kidney Disease
• 22. мај ·

  Yahoo
  When Will Vivoryon Therapeutics N.V. (AMS:VVY) Become Profitable?
• 15. мај ·

  Yahoo
  Vivoryon Therapeutics N.V. to Report Q1 2024 Financial Results and Operational Progress on May 23, 2024